Use of GeriKit to Better Phenotype Older Adults With Ischemic Heart Disease
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: GeriKit Mobile Application.
- Who it may be relevant to
- Registry conditions: Ischemic Heart Disease. Basic parameters: 75 years — 100 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study seeks to expand the use of the NYU GeriKit mobile application ("app") in a diverse range of settings to better phenotype older patients, which will enhance both research and patient care.
Detailed description
This is a single-center proof of concept study of geriatric impairments and feasibility metrics through the use of the GeriKit software application in older adults with ischemic heart disease at the NYU Langone Medical Center. The GeriKit mobile application was developed to make geriatric assessment instruments easily accessible to clinicians who do not have subspecialty training in geriatrics. The GeriKit app has been used clinically but is untested in research settings.
Interventions
- Procedure GeriKit Mobile Application
Digital health app used for comprehensive geriatric assessment (CGA). The app includes a series of brief, well-validated instruments: the MiniCog, 30-Second Chair Stand, Activities of Daily Living, Instrumental Activities of Daily Living, Patient Health Questionnaire (PHQ-9), Mini Nutrition Assessment, 2-Item Fall Screen, and Polypharmacy screen.
Primary outcome measures
- Incidence of Mortality or Hospital Readmission [Time frame: Month 6]
Secondary outcome measures (4)
- 12-Item Short Form Survey (SF-12) Score [Time frame: Baseline]
- 12-Item Short Form Survey (SF-12) Score [Time frame: Month 6]
- Seattle Angina Questionnaire Short-Form (SAQ-7) [Time frame: Baseline]
- Seattle Angina Questionnaire Short-Form (SAQ-7) [Time frame: Month 6]
Eligibility criteria
Inclusion criteria
- Age ≥ 75
- Currently hospitalized for acute mycardial infarction (AMI), percutaneous coronary intervention (PCI), or coronary artery bypass grafting (CABG); or hospitalized for AMI, PCI, or CABG within the prior 4 weeks
- Capable of self-consent
- Understand and are able to perform study procedures in English
Exclusion criteria
- Non-ambulatory
- Moderate or severe cognitive impairment (operationalized as known diagnosis of dementia)
- Unable or unwilling to consent
- Incarcerated
- Unable to use complete assessments in English
- Unable to complete geriatric assessment for other reasons
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Screening
Study locations
United States · 1 center
- NYU Langone Health — New York
Identifiers
NCT: NCT05788666 · 22-00841